Several extensions at the C terminus of YQLENYC were tolerated by AI4 (71), suggesting the potential of spliced peptides to be recognized by pathogenic beta cell-cytotoxic CD8+ T cells in T1D and to serve as additional, or perhaps even sole, ligands for them. This evidence concerns the gene CD8A and type 1 diabetes mellitus.